ABSTRACT: Impaired descending pain inhibition has been linked to chronic pain and poorer patient outcomes. Vibration perception threshold (VPT) has also been observed and linked to radiographic stage of OA. However, it is not known how duration of symptoms may influence these neurophysiological measures. Our purpose was to evaluate the relationship between duration of symptoms and conditioned pain modulation (CPM), a measure of descending pain inhibition, and VPT, and to determine whether these relationships differed in men and women seeking orthopedic care. We evaluated 18 men and 27 women with moderate to severe knee OA. We assessed CPM using a submaximal-effort tourniquet test: Pressure pain threshold (PPT) at the symptomatic knee was evaluated before and after a noxious stimulus. CPM impairment was indicated by a ratio of pre-to-post stimulus PPT !1. VPT was assessed using a biothesiometer at the medial femoral condyle. We used chi-square, t-tests and Pearson correlations to address study questions. 72% of men, but only 44% of women had CPM impairment. Duration of symptoms was associated with CPM impairment in women (R ¼ 0.566, p ¼ 0.003) but not men (R ¼ 0.366, p ¼ 0.135). Duration of symptoms was also associated with VPT in both men (R ¼ 0.580, p ¼ 0.012) and women (R ¼ 0.406, p ¼ 0.039). These results suggest that longer duration of knee OA may predict more severe pain sensitization and that important sex differences exist in descending pain inhibition in people with chronic knee OA that may affect disease and course of treatment in male and female patients. ß
Pain is a clinical hallmark of knee osteoarthritis (OA), a disabling, progressive, degenerative disease that commonly results in decreased function and perceived instability during activity. Management of the patient with knee OA related pain is challenging. While some studies contend that radiographic changes in the knee joint and pain are correlated, 1 others suggest a discordance between structural disease, severity and pain. 2, 3 In addition, the experience of pain changes as the disease progresses. Initially, occasional, intermittent activity-related pain is commonly reported; chronic pain that is punctuated by intermittent breakthrough pain becomes prominent as the disease progresses. 4, 5 Moreover, pain can be stable for many years in some, but progressive in others, 6, 7 further indicating that OA and pain may be separate but related processes. Finally, chronic knee OA pain is not always relieved by total knee arthroplasty (TKA). Up to $30% of TKA patients report persistent postoperative pain. 8, 9 A better understanding of factors related to chronic pain is needed so that clinicians can recognize patients at risk for chronic pain-this is perhaps especially important for individuals considering TKA.
Neurobiological mechanisms likely contribute to chronic pain in knee OA. It is now well-established that central and peripheral sensitization are present in knee OA. [10] [11] [12] [13] [14] [15] [16] [17] Peripheral sensitization is defined as the facilitated response of nociceptive neurons located at the site of tissue injury or disease; it is limited to these nociceptors and will resolve as tissues heal and inflammation recedes. Central sensitization is mediated via amplification of signaling to the central nervous system, potentially at both spinal and supraspinal levels, and is associated with heightened pain, spontaneous pain without trigger, expanded distribution of pain, and potentially the presence of altered non-nociceptive findings, including diminished vibration perception threshold (VPT) particularly in region of most pain. 18 Altered somatosensory findings in persons with chronic knee OA, such as VPT may serve as a clinical correlate of pain-related central neurophysiological changes. Besides heightened pain sensitivity, impaired descending pain inhibition may also contribute to the development of chronic pain generally, 19 and in knee OA specifically. 17, 20 The inability to dynamically suppress incoming nociceptive input may lead to widespread pain and reduced quality of life. Impaired descending pain inhibition is also associated with adverse treatment outcomes in some studies, [21] [22] [23] including outcomes of TKA. Pain management may be complicated by the fact that the experience of knee OA pain can be different in men and women throughout the disease process. 7, 16, [24] [25] [26] Studies suggest that deep tissue sensitivity is more common in women with OA than men with OA. 12, 16 It has also been reported that descending pain inhibition, measured via conditioned pain modulation (CPM) is more effective in healthy men than in healthy women, 27, 28 but this has not been specifically established in people with knee OA. Moreover, most of what we know about pain processing or sex differences in knee OA comes from studies that have recruited subjects from the community. These subjects may not reflect the characteristics of people who are actively seeking medical care. 25, 29 As new interventions emerge, it is critical that we understand relevant sex-differences in people seen in a clinical setting so that we can provide optimal care to both male and female patients. The purpose of this study was to determine if there is a relationship between disease chronicity (duration of symptoms) and measures of CPM and VPT, and to determine whether this relationship differed in men and women seeking orthopedic care.
METHODS

Study Design and Setting
This was a Level II Prognostic cross-sectional study involving a knee OA subject cohort from a previous study. 13 This study was approved by the Institutional Review Board of the University of Illinois at Chicago. Subjects were recruited from a single clinical practice in an urban academic health center.
Participants
All subjects were patients with moderate to severe clinical knee OA. Inclusion criteria were physician-diagnosed tibiofemoral OA with Kellgren-Lawrence Grade 2 or higher radiographic changes. If subjects had bilateral OA, the more painful knee was considered the study knee. Exclusion criteria were prior total knee arthroplasty, prior diagnosis of neurological or other rheumatological conditions, diabetes, and ligament deficiency. Subjects were asked to refrain from taking anti-inflammatory or pain medications during the 24 h prior to testing.
Characterizing Disease Duration and Clinical Status
Prior to testing, duration of symptoms, pain, and function were recorded. Duration of symptoms was assessed in months by patient self-report. Knee pain at rest and during walking was assessed using a visual analog scale (VAS) where 0 represents no pain and 10 represents the worst pain possible. Finally, subjects completed the Knee Outcome Survey (KOS) activities of daily living subscale. 30 The KOS consists of 16 questions involving the effect of symptoms (e.g., grinding, swelling) on daily activities, and perceived interference with activities including walking and rising from a chair. All questions are graded from 0 (worse possible) to 5 (best possible). To score the KOS, answers are summed and a percent of maximum possible points (80) is calculated. Thus the final KOS score ranges from 0 to 100%, where 100% represents full perceived knee function during activities of daily living.
Conditioned Pain Modulation Assessment CPM evaluation was described in the previous study. 13 Briefly, CPM was examined using a submaximal-effort tourniquet test. 31 Pressure pain threshold (PPT) was used as the test stimulus and was measured at the medial joint line of the study knee, before and after application of a painful conditioning stimulus. Impairment in CPM was operationally defined as no change or a reduction in PPT after application of the painful conditioning stimulus. The conditioning stimulus was a blood pressure cuff inflated to 280 mmHg on the contralateral arm and maintained for 6 min. Subjects were asked to rate the pain of the conditioning stimulus at 1-min intervals, and at 6 min, all subjects had rated the pain at !50/100 mm on the VAS, with 100 equating to the worst pain imaginable. To measure PPT, an algometer (JTECH Medical, Midvale, UT) was applied to the medial joint line of the affected knee. Pressure was gradually increased at 50 kPa/s. Both testers and subjects were blinded to the results of PPT testing. The pressure threshold at which the subject reported pain was recorded and the average PPT from three trials was calculated, with a 20 s time interval between trials. This was followed by application of the painful conditioning stimulus as described above. PPT was measured again within 30 s following termination of the conditioning stimulus. 32 We analyzed CPM as both a continuous variable (Pre-stimulus PPT/Post-stimulus PPT ratio) and a categorical variable (impaired vs. not impaired, i.e., Pre-stimulus PPT/Post-stimulus PPT ratio ! 1 vs. Prestimulus PPT/Post-stimulus PPT ratio <1) (Figure 1 ).
Vibration Perception Threshold
Assessment of VPT has been described elsewhere. 13, 33 VPT was measured at the bony landmark of the medial femoral condyle, using a biothesiometer (Bio-Medical, OH). A cylindrical stylus, 13 mm in diameter, vibrating at 100 Hz, was allowed to rest at the site of application. The amplitude of vibration (expressed in "biothesiometer units" 34 ) was increased until the participant reported an initial sensation of vibration. The biothesiometer was left in place and a second assessment was made. The average of these two results was calculated and recorded.
Statistical Analysis
Statistical analysis was conducted using SPSS software V.24 (IBM SPSS, IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp). Pearson correlations were used to determine whether or not there was a different association between duration of symptoms and either CPM or VPT. Men and women were analyzed separately. To address our secondary aim, t-tests were used to determine differences in PPT between men and women for the purpose of capturing sex differences in baseline deep tissue sensitivity. T-tests and chi-square tests were used to determine whether or not CPM measures were different in women and men. Finally, t-tests were used to determine whether or not VPT was different in women and men. Although an a priori power analysis was not possible, given that these data were previously collected, we calculated effect sizes that could be detected at the p < 0.05 level with 80% power using G Ã Power software. We found that a correlation coefficient of 0.403 could be detected for the entire group (n ¼ 45), a correlation coefficient of 0.509 could be detected for the group of women alone (n ¼ 27) and a correlation coefficient of 0.606 could be detected for the group of men alone (n ¼ 18). Further, we found that an effect size of 0.87 could be detected in a t-test with two groups of n ¼ 18 and n ¼ 27 with 80% power.
RESULTS
Forty-five subjects satisfied inclusion exclusion criteria (Table 1) . We noted that BMI was significantly different between men and women (p < 0.001). Thus, before statistically evaluating our hypotheses, we confirmed that BMI, as well as age, function (measured using the Knee Outcome Score), baseline rest pain, and baseline walking pain were not associated with either prestimulus or post-stimulus PPT measures, level of CPM impairment, or VPT. We found that BMI was associated with VPT (R ¼ 0.307, p ¼ 0.040) but there were otherwise no statistically significant associations (R ¼ À0.002 to 0.150, p ¼ 0.326 to 0.987). We also evaluated sex differences in the extent of CPM and VPT. Baseline PPT was not different between men and In addition, we found that longer duration of symptoms was correlated with greater deficits in VPT after adjusting for BMI (R ¼ 0.526, p ¼ 0.001). The strength of the association was slightly higher in men, however (Figure 4 ). Based on R 2 values, months with OA predicted 34% of the variability in VPT in men but only 16% in women, after adjusting for BMI. We conducted a final analysis to determine whether the associations between duration of symptoms and both CPM and VPT were mirrored in self-reported pain and function measures. Duration of symptoms was not associated with either resting pain or walking pain (R ¼ À0.091 and À0.218, p ¼ 0.557 and 0.155). Duration of symptoms was also not associated with KOS scores (R ¼ À0.086, p ¼ 0.581). No associations emerged when men and women were analyzed separately (p ! 0.155).
DISCUSSION
The purpose of this study was to examine the effect of disease chronicity and measures of central pain processing by examining the association between months with OA symptoms and CPM and VPT. A secondary purpose was to determine whether there were differences in these associations between men and women. The rationale for this secondary analysis was that some studies have reported differences in the pain experience between male and female patients with knee OA. We found a relationship between disease chronicity and CPM impairment, but that association was only seen in women. In addition, there was also a relationship between disease chronicity and worse VPT. This association was seen in both men and women.
Longer duration of symptoms was associated with worse CPM impairment in women. Abnormal descending pain inhibition has been linked to chronic pain, 19 which is more common in women. It is unclear from existing studies, including this one, whether abnormal 
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descending pain inhibition predisposes affected people to experiencing chronic pain, or whether altered neurophysiologic processing underlying chronic pain triggers abnormal descending pain inhibition. It is known that descending pain inhibition is a dynamic process, activated when the need to suppress nociceptive input is required. Researchers have suggested that continued activation of these pathways, which occurs with chronic pain conditions, may decrease its effectiveness. 19 Thus, chronicity may be an important factor in appropriate management of this condition.
Clinical trials in knee OA have demonstrated that longer pain duration has been associated with poorer outcomes. 35 In addition, abnormal descending pain inhibition may predict poor pain outcomes after total knee arthroplasty, 21, 23 and women may be at increased risk for have poorer total knee arthroplasty outcomes. [36] [37] [38] There are currently no validated appropriateness criterial for knee arthroplasty-moreover, women tend to delay surgery until their symptoms are more severe than their male counterparts. 24, 25, 39 An extrapolation of these findings may ultimately show that encouraging women to undergo TKA sooner in the disease course, before CPM becomes impaired may be one strategy to decrease the likelihood of persistent postoperative pain. Alternatively, some patients may benefit from interventions to improve CPM. 13 Longitudinal studies are needed to determine how CPM impairment evaluation may influence OA clinical care throughout the disease course.
Enhanced CPM has been associated with participation in exercise, 40 thus individuals with CPM impairment in this study may have lived a more sedentary lifestyle than those with intact CPM. Regular physical activity has been demonstrated to prevent development of chronic muscle pain. 41 Future studies of CPM in persons with knee OA should clearly evaluate exercise history as a potential factor mediating impaired descending pain inhibition. In addition, it may be important to examine the effects of non-pharmacological/non-surgical interventions such as exercise on individuals with chronic knee OA pain and CPM impairment.
The relationship between impaired VPT and duration of symptoms may be a significant factor in reported functional deficits reported in individuals with knee OA. Dynamic knee joint loading has been directly associated with impaired VPT in persons with knee OA, meaning that the worse the vibratory sense, the higher the knee load during gait. 42 In addition, Kavchak found increased perceived instability during a step up and over task was correlated to increased vibratory hypoesthesia at the knee. 43 It has been suggested that pain may inhibit non-nociceptive afferent input causing hypoesthesia at the painful body part. 44 Accordingly, Harden et al found over 30% of individuals with knee OA demonstrated hypoesthesia to VPT on their worse knee but only 20% on the contralateral knee. 45 As a consequence, it is possible that hypoesthesia may result in altered motor control and altered joint loading. 42 This may be critical considering the varying progression of osteoarthritic changes in some individuals. No differences were found between men and women in VPT, indicating that sex differences may be less a factor in knee OA related hypoesthesia.
A surprising result was that there were no differences in CPM between men and women. Furthermore, a greater proportion of men than women had impaired CPM. Sex differences in descending pain inhibition, measured via conditioned pain modulation, has not been previously evaluated in this population. However, based on studies of healthy subjects, we expected to find CPM differences. In one recent review of studies involving healthy individuals, 28 fifteen studies were identified that examined sex differences in CPM. In nine studies, no sex differences were found, with variable results in the remaining studies. In most, however, healthy men had more effective CPM than healthy women. Popescu et al. reported similar findings. 27 As mentioned above, this may relate, in part, to the exercise background of these individuals, which typically is not reported in these studies. In addition, it is possible that chronic knee OA may alter this typical sex distribution. Alternatively, the men in this study may have had more severe radiographic OA than the women, or may have paid less attention to symptoms in the early stages of the disease. Future studies that account for radiographic severity are needed to determine if knee OA structural changes play a role.
Notably, most previous studies in this area have been in community-based subject samples. 12, 16 In contrast, this study involved people who were specifically seeking orthopedic care. Other studies have demonstrated that individuals already seeking care from an orthopedic surgeon have different characteristics than community dwellers who are not patients. 25, 29 More work is needed to determine how the characteristics of knee OA patients from different settings relate to impaired conditioned pain modulation and sensitization.
There were a few limitations to this study, most of which are inherent to any secondary analysis. First, we did not record menstrual and menopausal status, which may affect PPT and CPM in women. 19, 28 Second there were more women than men with knee OA in this study. While an equal number might have been preferable, this distribution does, however, mirror the greater prevalence of knee OA in women in population studies. 46, 47 For this reason, we believe that this study sample is representative of knee OA patients that would typically be seen in a clinical orthopedic setting. We note that others have noted an association between age and VPT. 42 This was not seen in our sample for reasons that are unknown. We cannot rule out that the study was underpowered to detect such an association. Finally it is important to note that we did not control for radiographic OA severity. Although the relationship is imperfect and there is variability in rates of progression, it is possible that higher duration of disease was associated with worse radiographic OA. In this case, our measure of chronicity would represent a combination of duration of symptoms and level of radiographic severity.
In conclusion, this study demonstrated that a longer duration of symptoms was significantly associated with worse VPT and, in women only, worse CPM impairment. A caveat is that we cannot determine whether or not severity of radiographic OA influenced these findings. These results suggest that longer duration of knee OA may predict more severe pain sensitization and that there are important sex differences in descending pain inhibition in chronic knee OA that may affect disease and treatment courses in male and female patients. Further, these findings extend previous studies that link radiographic OA severity and VPT, and add a potential link with CPM. The association between duration of symptoms and CPM has particular clinical implications. CPM can be assessed easily in a clinical setting and can predict treatment outcomes including that of TKA. 21 Moreover CPM may respond to rehabilitation, such as the joint mobilization intervention evaluated in our previous study. 13 Such nonpharmacological interventions can be important additions to our treatment arsenal given the risks, and in some cases, the limited benefit, of commonly used medications or medication classes (e.g., NSAIDS and opioids). [48] [49] [50] Future studies are needed to expand on these findings and determine whether CPM assessment and treatment can have a role in identifying appropriate surgical candidates, timing surgical interventions or optimizing patients before TKA. A better understanding of disease chronicity and any role of sex differences in pain processing can help lead to more effective interventions for knee OA, and reduce the sex and gender disparities reported in the literature. 38 
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